Integra LifeSciences IART Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $1.64B+1.2% | $1.64B+1.5% | $1.64B+5.0% | $1.62B+3.5% | $1.62B+6.2% | ||
| $790.34M+4.7% | $803.63M+10.3% | $783.14M+11.0% | $768.66M+11.6% | $754.65M+12.5% | ||
| $854.17M-1.8% | $831.62M-5.7% | $859.83M0.0% | $853.07M-2.8% | $869.66M+1.3% | ||
| 51.9%-1.6pp | 50.9%-3.9pp | 52.3%-2.6pp | 52.6%-3.4pp | 53.5%-2.6pp | ||
| $97.74M-13.6% | $98.97M-14.2% | $105.39M-2.8% | $110.37M+2.6% | $113.14M+8.3% | ||
| $696.44M-4.9% | $699.7M-2.4% | $708.95M+1.0% | $717.1M+4.5% | $732.68M+11.7% | ||
| $2.11B+30.7% | $2.13B+34.5% | $2.12B+38.3% | $2.12B+41.2% | $1.62B+11.4% | ||
| -$489.44M-5,568% | -$516.41M-1,918% | -$480.78M-1,768% | -$500.69M-888% | $8.95M-88.7% | ||
| -29.8%-30.3pp | -31.6%-33.3pp | -29.3%-31.1pp | -30.9%-34.9pp | 0.6%-4.6pp | ||
| $89.91M+18.6% | $86.26M+22.1% | $81.57M+24.7% | $78.21M+32.4% | $75.82M+43.3% | ||
| —— | —— | -$1.93M-139% | $1.03M-69.0% | $4.41M+157% | ||
| -$540.19M— | -$567.81M— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| -$495.8M— | -$516.47M— | —— | —— | —— | ||
| -30.1%— | -31.6%— | —— | —— | —— | ||
| -$6.46— | -$6.73— | —— | —— | —— | ||
| -$321.34M-288% | -$349.62M-283% | -$314.89M-271% | -$337.33M-259% | $171.35M-22.6% | ||
| -19.5%-30.1pp | -21.4%-33.2pp | -19.2%-30.9pp | -20.8%-34.4pp | 10.5%-3.9pp | ||
| -$489.44M-5,568% | -$516.41M-1,918% | -$480.78M-1,768% | -$500.69M-888% | $8.95M-88.7% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Integra LifeSciences's revenue?
- Integra LifeSciences (IART) generated $1.6B in revenue over the trailing twelve months, up 1.2% year over year.
- Is Integra LifeSciences profitable?
- Integra LifeSciences is not currently profitable: it reported a net loss of $495.8M over the trailing twelve months, a -30.1% net margin.
- What are Integra LifeSciences's profit margins?
- Gross margin is 51.9% and operating margin is -29.8%, with a -30.1% net margin.
- What is Integra LifeSciences's earnings per share?
- Integra LifeSciences's diluted EPS over the trailing twelve months is $-6.46.
- Where does Integra LifeSciences's income statement data come from?
- Every line is extracted from Integra LifeSciences's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
